Us Bancorp »

Biomarin Pharmaceutical shares owned by Us Bancorp

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Us Bancorp

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.8k 5.0k 0.95

More positions owned by Us Bancorp

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Core Msci Emkt (IEMG)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)

View all positions for Us Bancorp

Top funds holding Biomarin Pharmaceutical

MacKay Shields
Ing Investment Management
Wellesley Investment Advisors
Lazard Asset Management
Victory Capital Management
Thrivent Financial for Lutherans
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
State Street Corporation
Schroder Investment Management Group
Morgan Stanley
Sonora Investment Management Group
Leucadia National Corporation
Franklin Resources
Bank of America Corporation

View all funds holding Biomarin Pharmaceutical